Kurs
-0,82%
Kurs
-0,82%
Open
19,11
High
19,76
Low
17,89
Close
18,46
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
| Est. tid* | ||
| 2026-06-24 | N/A | Årsstämma |
| 2026-03-05 | 06:10 | Bokslutskommuniké 2025 |
| 2025-11-26 | 06:10 | Kvartalsrapport 2025-Q3 |
| 2025-09-17 | 06:10 | Kvartalsrapport 2025-Q2 |
| 2025-06-26 | N/A | X-dag ordinarie utdelning SOFTX 0.00 NOK |
| 2025-06-25 | N/A | Årsstämma |
| 2025-06-10 | 06:10 | Kvartalsrapport 2025-Q1 |
| 2025-03-26 | - | Bokslutskommuniké 2024 |
| 2024-12-20 | - | Extra Bolagsstämma 2024 |
| 2024-11-27 | - | Kvartalsrapport 2024-Q3 |
| 2024-09-12 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-28 | - | Kvartalsrapport 2024-Q1 |
| 2024-06-27 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
| 2024-06-26 | - | Årsstämma |
| 2024-03-20 | - | Bokslutskommuniké 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-09-26 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-21 | - | Årsstämma |
| 2023-06-21 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-30 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-12-09 | - | Extra Bolagsstämma 2022 |
| 2022-10-26 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-15 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-19 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
| 2022-04-17 | - | Årsstämma |
| 2022-02-16 | - | Bokslutskommuniké 2021 |
| 2021-12-29 | - | Extra Bolagsstämma 2021 |
| 2021-11-17 | - | Kvartalsrapport 2021-Q3 |
| 2021-09-08 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-14 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
| 2021-04-13 | - | Årsstämma |
| 2021-02-09 | - | Bokslutskommuniké 2020 |
| 2020-12-14 | - | Kvartalsrapport 2020-Q3 |
| 2020-09-30 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
| 2020-06-30 | - | Årsstämma |
| 2020-06-30 | - | Kvartalsrapport 2020-Q1 |
| 2019-12-20 | - | Extra Bolagsstämma 2019 |
| 2019-06-27 | - | Årsstämma |
| 2019-06-03 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
| 2018-07-02 | - | Split SOFTX 1:50 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2021-06-07 07:00:00
SoftOx Solutions AS (SoftOx) aims to develop an inhalation solution (SIS) for
the treatment of respiratory tract infections. This has the potential to be a
breakthrough in the future treatment of respiratory infections, including
viruses, bacteria and fungal infections.
"After an intensive research phase, we are very satisfied that the Danish
Medicines Agency (DKMA) considers our documentation positively and has given a
conditional approval to be able to start the study", says Medical Director Glenn
Gundersen. "The conditions that have been communicated are related to additional
safety data and the company is already working on completing the data as
requested. The data will be provided in due time and we believe that the study
can be initiated during the autumn."
For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS, or
Glenn Gundersen, Medical Director in SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599
About SoftOx Solutions AS
SoftOx Solutions AS is a Norwegian BioTech company listed on Euronext Growth
Oslo. Our Vison is "Helping the world fighting infections - developing new ways
of eradicating infections and fighting antimicrobial resistance". We are working
to combat major threats to human health, namely the emergence of antimicrobial
resistance (AMR), biofilm infections in chronic wounds and the spread of
viruses. For more information on SoftOx, visit www.soft-ox.com.